The NASA-Sponsored Study of Cataract in Astronauts (NASCA). Relationship of Exposure to Radiation in Space and the Risk of Cataract Incidence and Progression. Report 1: Recruitment and Methodology by Chylack, Leo T. et al.
  
 1
 
 
The NASA-Sponsored Study of Cataract in Astronauts (NASCA).  Relationship of Exposure to 
Radiation in Space and the Risk of Cataract Incidence and Progression. Report 1: Recruitment 
And Methodology 
 
 
Leo T. Chylack, Jr., M.D.a, Leif E. Peterson, Ph.D.b, Alan H. Feiveson, Ph.D.c, Mary Wear, Ph.D.d 
F. Keith Manuel, O.D.e, William H. Tunga, Dale Hardy, M.Sb, Lisa Marak, R.N.d, Francis A. 
Cucinotta, Ph.D.c 
 
aCenter for Ophthalmic Research, Brigham and Women's Hospital, Boston, MA 
bDepartment of Medicine , Baylor College of Medicine, Houston, TX 
cLyndon B. Johnson Space Center, NASA, Houston, TX 
dWyle Laboratories, Houston, TX 
eSpace Center Eye Associates, Houston, TX 
 
 
 
 
 
 
 
Running title: NASCA Study – Recruitment and Methodology. 
 
 
 
Key words:  Cataract, space radiation, astronaut, longitudinal cohort study 
 
 
 
 
 
 
 
 
 
 
 
Corresponding Author: 
 
Leo T. Chylack, Jr., M.D. 
Center for Ophthalmic Research  
EBRC Rm 323 
221 Longwood Ave.  
Boston, MA 02115 
Tel: (781) 934-5052 
Fax: (781) 934-2747 
Email:  ltchylack@rics.bwh.harvard.edu 
 
  
 
https://ntrs.nasa.gov/search.jsp?R=20070031168 2019-08-30T01:40:28+00:00Z
  
 2
 
ABSTRACT 
 
  
 
  
 3
 
INTRODUCTION  
 
 
The NASA Study of Cataract in Astronauts (NASCA) is a five-year, multi-centered, investigation 
of lens opacification in populations of U.S. astronauts, military pilots, and ground-based (non-
aviator) comparison participants.  For astronauts, the explanatory variable of most interest is 
radiation exposure during space flight, however to properly evaluate its effect, the secondary 
effects of age, nutrition, general health, solar ocular exposure, and other confounding variables 
encountered in non-space flight must also be considered. NASCA contains an initial baseline, 
cross-sectional objective assessment of the severity of cortical (C), nuclear (N), and posterior 
subcapsular (PSC) lens opacification, and annual follow-on assessments of severity and 
progression of these opacities in the population of astronauts and in participants sampled from 
populations of military pilots and ground-based exposure controls. From these data, NASCA will 
estimate the degree to which space radiation affects lens opacification for astronauts and how 
the overall risks of each cataract type for astronauts compared with those of the other exposure 
control groups after adjusting for differences in age and other explanatory variables.  
 
During space flight, the average lens dose of space radiation varies with the mission (see Table 
1, Column 4). The highest radiation risk missions occurred on the Skylab, Russian Mir, and the 
International Space Station (ISS) missions because of their long duration. The Hubble telescope 
launch and repair missions were of moderate duration (<2 weeks), however astronauts received 
higher exposures from trapped protons in the Earth’s radiation belts due to the location of the 
Hubble telescope, a distance above Earth of 600 km. The Apollo missions’ orbits were outside of 
Earth and were of much shorter duration, however in these missions astronauts were exposed to 
the complete galactic cosmic ray environment during the trip to the moon.  The earlier Mercury 
and Gemini missions were of short duration and at low orbital inclinations. The space shuttle 
program has been the longest occurring NASA program with over 110 missions since 1982. 
These missions have lasted about 14 days on average, however astronauts often participate in 
several missions and cumulative doses may accumulate to a higher levels with a maximum to 
date of seven missions flown by two astronauts.   In addition, there are significant qualitative and 
quantitative differences between terrestrial and celestial radiation. Whereas terrestrial radiations 
are low LET (linear energy transfer) and derived from x-rays and gamma rays, celestial 
radiations are high LET and derived from heavy ions and secondary neutrons. Terrestrial x-ray 
and γ-ray exposures have been linked with increased cataract risk, but the precise 
cataractogenic risks of the various components of celestial radiation have not been defined. 
Many factors contribute to the average lens mission radiation dose, and if NASA is to understand 
the mechanism(s) by which space radiation increases the risk of cataract, a comprehensive 
study of astronauts and appropriate control groups is needed.  To date, there has only been one 
systematic investigation of lens opacification among U.S. astronauts(1), which reported an 
increased risk of cataracts in astronauts with lens exposures of >8 mSv compared to those 
having lens exposures <8 mSv.  Because these results were based on subjective and non-
standardized lens evaluation techniques, and because NASA is planning prolonged manned 
space missions to the moon and to Mars, NASA funded this study to evaluate lens opacification 
in astronauts using standardized and validated objective techniques.   
 
NASCA employs a longitudinal cohort study which samples on exposure in order to compare 
cataract prevalence and incidence among exposed astronauts with cataract prevalence and 
incidence among non-exposed comparison subjects (exposure controls). The most important 
factor considered when choosing the suitable comparison population for astronauts was the 
lifestyle difference surrounding health and fitness.  Active astronauts are selected through 
stringent medical criteria and are under continual medical surveillance to sustain qualified flight 
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status and optimal fitness. Exposure control populations available from the local occupational 
aerospace community are not under such strict health surveillance, and therefore have the 
potential to become, on average, less healthy and fit.  For this reason, we formed two 
subpopulations in the exposure control group: one consisting of subjects with a history of military 
aviation, and one without any military or commercial occupational aviation history.  The former 
group of exposure controls is referred to as “aircrew”, since the requirement to be in this group 
was to be part of military aircrew (e.g., pilot, co-pilot, navigator, radar/sonar operator, loadmaster, 
etc.).  As such, their medical history at least parallels the flight medicine experience of 
astronauts.  The latter group is referred to as “ground-controls,” for which health and fitness was 
not expected to mirror the astronauts nor aircrew controls.    
 
The operational approach to NASCA is being carried out in two stages.  In the first stage, a 
cross-sectional analysis of baseline (Year-1) data will be performed to assess the prevalence of 
cataract and identify associations between cataract, space radiation, and other host/risk factors.  
The second stage will consist of a longitudinal analysis to identify the incidence of cataract over 
the repeated annual eye exams adjusted for host/risk factors.  In both stages, we will perform 
between-group and within-astronaut comparisons and dose-response modeling.  This manuscript 
reports on the recruitment effort, the composition of the three cohorts (astronauts, aircrew, and 
ground-based controls) and provides basic, baseline data by group for: general demographics, 
ocular and lenticular health, nutrition, solar UV- and space-radiation exposures. This first report 
also describes and references the methods used in the NASCA project. 
 
The specific aims of the NASCA study are: 
 
1. To determine the prevalence of age-related C, N, and PSC lens opacities in the complete 
sample of astronauts and control populations (military aviators and ground-based subjects), and 
determine the risk or cataract associated with radiation exposure during space flight. 
 
2. To determine the prevalence of age-related C, N, and PSC lens opacities and risk of cataract 
associated with non-space flight among the control subjects.  
 
3. To modify the ocular assessment protocol in the astronauts' regular annual medical 
examination to improve the assessment of the status of the crystalline lens. 
 
4. To determine the progression of C, N, and PSC lens opacities in the complete sample of 
astronauts, the control populations of military aviators and ground-based subjects, and then 
determine the risk factors associated with cataract progression with a specific focus on the 
components and doses of radiation exposure during space flight. 
 
Specific aims 1-2 will be determined using baseline data collected during the cross-sectional 
phase (year 1) of the study, while aim 4 on progression will be determined from the longitudinal 
phase (years 1-5).  This report describes the recruitment effort and results for the NASCA study 
and provides detailed descriptions about the sampling procedures, enrollment, and statistical 
comparisons of the enrolled subjects.  Other papers are being developed to report etiological 
(cause-effect) statistical modeling results and synthesize findings with current knowledge on 
radiobiological and clinical aspects of density opaque and cataract.  
 
 
METHODS     
 
Human Subjects Committee (HSC) Approvals: Prior to recruiting, approval of the NASCA study 
protocol was obtained from the HSCs at Baylor College of Medicine (BCM), Johnson Space 
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Center (JSC), and the Brigham and Women’s Hospital (BWH). Details of the informed consent 
documents are available on the NASCA web site (list NASCA web site URL). 
 
Subject enrollment. Figure 1 illustrates the distribution and enrollment of all subjects expressing 
an interest in participating in the NASCA project.  Individuals interested in participating were 
either excluded because they failed to meet all of the NASCA inclusion/exclusion criteria or 
enrolled because they met all exclusion/inclusion criteria (designated “eligibles”).  All “eligibles” 
were consented, scheduled for a baseline examination, and those who met all exam criteria were 
entered into the full protocol (and designated active subjects).  Likewise, those who met 
exclusion criteria were excluded from the study. We anticipated that some active subjects would 
drop out.  As the study progresses, we will report data on subjects who complete the study and 
also on those who drop out (including any deaths, exclusions for cause, etc.). 
 
Instruments (Questionnaires). All astronauts are required to have standardized annual 
medical/ocular examinations as part of routine flight medicine surveillance. Astronaut recruitment 
was initiated by mailing informational packets containing informed consent forms, lay summaries, 
invitation letters, a Demographics-Health-Sunlight Exposure Questionnaires (DHSEQ), and 
Harvard Food Frequency Questionnaires (HFFQ) one month prior to the annually scheduled 
examination (active astronauts) or annual exam anniversary (retired astronauts).  Interested 
subjects were asked to bring completed paperwork to their next annually scheduled appointment.  
We mailed similar informational packets to potential exposure controls who responded to 
advertisements in local newspapers and NASA-sponsored electronic newsletters sent to NASA 
and contractor employees.  Exposure controls were asked to return their signed consent forms 
and completed DHSEQs and HFFQs if interested in participating in the study. The military 
aviation history of the aircrew exposure control group was based upon self-reporting.  The details 
of the recruitment procedures are found on the NASCA web site [give URL]. 
  
At the time of the baseline vision exam, the study was explained in full to each subject by the 
optometry staff.  All completed data forms for consenting subjects were given to the Data 
Coordinator. The Data Coordinator also merged demographic, health, and sunlight exposure 
data into each subject’s folder and electronic medical record.  All study subject folders were kept 
in secure files. All DHSEQs and HFFQs were delivered to the Forms Manager proper handling.  
The DHSEQ was administered to all subjects only at baseline; however, the HFFQ was 
administered to all study participants at baseline and at each follow-up visit (2).   Regarding the 
DSHEQ, subjects were asked for basic identification data and demographic information such as 
birth date, age, gender, local address, and contact information.  DHSEQ data were gathered on 
personal health history, medical conditions diagnosed by a physician, ocular medical history 
(cataracts, glaucoma, macular degeneration), past and current medications, ground-based ocular 
sunlight exposure since age 30, current use of glasses, contact lenses, (or other protective 
devices), percent of time sunglasses and hat were worn out doors, and time spent on the water. 
Smoking and ethnicity information were collected in year 2 of the study using a separate form. 
Subjects were asked to self-report their previous and current smoking histories and to self 
identify their ethnicity and racial group. 
 
Ocular examination protocol.  The optometric staff performed the standard astronaut ocular 
exam on all subjects during their baseline and annual visits.  This protocol includes determination 
of the following.  Eye color: by inspection. Correction mode: spectacles (with sphere, cylinder, 
and axis specified) and contact lenses (with base curves and power specified), spectacle type, 
contact lens type, contact lens material, contact lens design, and contact lens schedule. 
Confrontation Visual Fields: were assessed unilaterally by finger counting in four quadrants at 
one meter. Visual acuity: distance vision uncorrected each eye and both eyes, distance vision 
corrected (if required) each eye and both eyes, near vision uncorrected each eye and both eyes, 
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and near vision corrected (only if needed) each eye and both eyes. Refraction: a manifest 
refraction was done in a 20 foot refracting lane to derive the best spectacle correction and the 
best-corrected visual acuity. High contrast, best-corrected Snellen visual acuity was measured 
with the Mentor B-VAT system, and high-contrast logMAR acuity was measured with the Early 
Treatment Diabetic Retinopathy Charts (4) (Numbers 2121,2122, 2123, 2152) according to the 
specified protocol.  The number of letters correct (each eye) and the LogMAR acuities each eye 
were specified. Low contrast acuity was measured with Precision Vision back-illuminated charts. 
See the NASCA web site for additional details.  Accommodation: measured in diopters and 
(measured how?).  Convergence: (Measured how?) were recorded.   Phorias: (Measured 
how?) were recorded.  Tropias: (Measured how?) were recorded.  Versions: (Measured how?) 
were recorded.  Intraocular pressure measurement: IOP determination with Goldmann 
applanation tonometry and expressed in mm Hg. Biomicroscopic (slit lamp) examination: A 
slit lamp evaluation of the adnexal and anterior segment tissues was done. Patients judged to 
have narrow angles were excluded. Pupillary dilatation: Both eyes were maximally dilated with 
1 gtt each of 0.5% proparacaine hydrochloride, Tropicamide 1.0%, and phenylephrine HCl 2.5%. 
Fundus examination was performed (With indirect ophthalmoscopy?) and findings of optic nerve, 
macula, retinal vessels, and periphery were recorded.  Lens Opacities Classification System, 
Version III (LOCS III) (3): LOCS III-trained and -certified optometrists performed LOCS III 
grading of nuclear color (NC) after maximal pupillary dilatation was achieved. The NC scale is 
obtained by comparison to six standard images comprised of six standard images illustrating 
varying degrees of nuclear opalescence and color. The scale ranges from the lowest value of 0.1 
to the highest value of 6.9. A lens given a LOCS III NC grade of 0.1 is essentially colorless. A 
lens with a LOCS III NC grade of 3.0 has a lemon-yellow brunescence. A lens given a LOCS III 
NC grade of 6.9 has advanced reddish-brown nuclear brunescence. We will ascertain if higher 
LOCS III NC scores contributes to the increased uncertainty associated with the objective 
assessment of mean pixel density in Scheimpflug slit images.  LOCS III Training and 
Certification of staff: A formal training session and a written test of competence was given to 
each of the NASCA optometrists (Drs. Manuel, Maxwell, Izsard, Gibson, and Choi). These 
training materials are found on the https://locs.webex.com web site.  Nidek EAS 1000 Lens 
Imaging: The Nidek EAS 1000 Lens Imaging System (5) was used to capture a single 
black/white digital Scheimpflug slit and two retroillumination images of the lens. One retro image 
was focused at the plane of the anterior capsule and the second was focused at the plane of the 
posterior capsule. Technically unsatisfactory images were rejected and new images were 
obtained prior to data storage.  Image Analysis Protocols: Both retroillumination and 
Scheimpflug slit images were analyzed using the Nidek EAS-1000, version 1.23E program.  The 
details of the protocols described briefly below are available on the NASCA website. All analyses 
were performed by one analyst (WHT), and each analysis was checked for accuracy by LTC. 
Innaccurate analyses were repeated according to specific instructions by LTC.  Image Analysis 
of Nidek EAS 1000 Digital Slit and Retroillumination Images: Protocols were used to 
measure the total areas of cortical and PSC cataracts. We devised methods for assessing each 
separately in cases of mixed cataracts. We assessed ocular biometry and mean nuclear density 
at three nuclear loci (central clear zone, centers of the anterior, and posterior embryonal nuclei) 
in Scheimpflug slit images from this lens imaging system.  Confrontation Field Testing: 
Confrontation fields were assessed unilaterally by finger counting in four quadrants at 1 meter.  
Color Vision:  Color vision was assessed with Pseudo-Isochromatic 15 Color Plates under 
proper illumination. If 10 or more plates were correctly identified, color vision was classified as 
normal.  Depth Perception: was assessed by means of Optec 2300 (Stereo Optical) tester. Six 
groups of circles were presented with varying degrees of circle separation. A subject’s stereopsis 
was designated as normal if s/he identified all circles at 20 seconds of arc. High and Low 
Contrast Sensitivity: This was done with Precision Vision (PV) Acuity charts.  
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Lens space radiation dosimetry. Radiation sources in space include contributions from trapped 
protons in the Earth’s Van Allen belts, galactic cosmic rays (GCR), and infrequent exposures 
from solar particle events (SPE) (7). The spatial and temporal variations of the GCR and trapped 
protons are determined by the sun’s approximately 11-year solar activity cycle with the flux 
variation more than 2-fold over a cycle, and by the orbital parameters of the mission due to the 
variation in radiation amounts within the Earth’s magnetic fields and radiation belts. The 
approach used at NASA is to utilize available radiation dosimetry from each mission in 
conjunction with space radiation transport models to estimate lens dose and dose equivalent (7-
9, 20). The space radiation transport models are needed because thermoluminescence 
dosimeter (TLD) badges worn one on the chest or hip by astronauts measure only the absorbed 
dose and not the spectra components of space radiation needed to estimate biological equivalent 
lens doses. Spectral measurements of LET or ion charge and energy, are measured by area 
detectors, but not at the astronaut’s body. Space doses are assumed to be made-up of two 
components representing GCR and trapped or solar particle contributions. The GCR contribution 
varies slowly with the amount of shielding and the trapped or solar radiation varies quite strongly 
becoming negligible at large shielding depth. This observation is used in a re-normalization 
procedure of transport code results first to flight specific area dosimetry and a second re-
normalization to individual astronaut TLD badge doses. Checks for accuracy are also made in 
comparisons to area spectral data. 
 
Assessment of ocular solar exposure.  In the NASCA study, we assessed the effective ocular 
exposure (OEeff), introduced by McCarty (10). OEeff, in units of sun-years, serves as a surrogate 
measure of cumulative ocular solar exposure, and partitions the number of hours spent outdoors 
during the working week and weekend, with adjustment for protective factors such as the 
percentage of time wearing a hat, wearing sun glasses, contact lenses, glasses, and whether the 
time outdoors is over water (fishing, boating, swimming, diving and snorkeling, water skiing, 
windsurfing, kayaking, etc.).  Data for calculating OEeff  were obtained during administration of the 
DHSEQ prior to the baseline eye exam.  Subjects were asked to first construct their geographic 
residence history from age 30 until the current age, and provide for each geographic location the 
number of years lived in the location, the number of hours spent outdoors and over water during 
the week and on weekends, and the percentage of time wearing a brimmed hat, sunglasses, 
glasses, or contact lenses.  Using the profile of ocular exposure throughout the residence history, 
a single value of OEeff was determined using methods described by McCarty (10).    
 
UV background rates for geographic areas of residence were not incorporated into OEeff, since 
the breakdown of residence history into geographic region as was done to queue the subject’s 
memory on lifestyle activity changes. Moreover OEeff was used to reflect the combination of 
cumulative exposure and protective habits.  The importance of assessing solar ocular exposure 
in the NASCA study is reflected in the known epidemiological and biological associations 
between ocular solar UV exposure and cataract. In 2002, McCarty and Taylor (11) reviewed 22 
published epidemiologic studies on ocular solar ultraviolet (UV) exposure and cataract for 
biological plausibility, strength of the association, specificity, experimental evidence, temporality, 
dose-response relationship, and consistency of findings.  Their results indicated that the majority 
of the studies met most of the epidemiologic criteria for causality and support an association 
between UV and the development of cortical cataract and perhaps posterior subcapsular 
cataract. They also concluded the epidemiologic data justify the implementation of public health 
campaigns to raise public awareness of the risk of cortical cataract due to ocular UV exposure.  
A molecular basis of UV-induced cataract has also been established, in which matrix 
metalloproteinases (12, 13), cytokines and growth factors (14-16), and beta crystallins (17) play 
an important role.   
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Statistical analysis: dimensional reduction of HFFQ data. The HFFQ resulted in 105 
continuously-scaled variables representing daily intake. In order to minimize the potential for 
overfitting due to the curse of dimensionality (e.g., too many variables) during statistical dose-
response modeling, the number of dimensions was reduced using principal components analysis 
(PCA).   Prior to PCA, the 105 variables were partitioned into 12 a priori food groups representing 
fats, omega fatty acids, fatty acids, carbohydrates, amino acids, A vitamins, B vitamins, B12-folic 
vitamins, C vitamins, D and E vitamins, minerals, and trace elements.  We left alcohol (gm), fiber 
(gm), caffeine (mg), and calories intact and did not assign these variables to any groups.  The 12 
nutrient groups and their constituent variables with units for daily intake are fats (animal fat gm, 
vegetable fat gm, total fat gm, saturated fat gm, monosaturated fat gm, saturated fat gm, 
polyunsaturated fat gm, cholesterol mg), omega fatty acids [linoleic gm, omega 3 (EPA, DHA, 
no alpha-linolenic acid) gm, linolenic fatty acid gm, eicosapentaenoic fatty acid (EPA) gm, 
docosapentaenoic fatty acid (DPA) gm, docosahexaenoic fatty acid (DHA) gm, omega 3 (EPA, 
DPA, DHA, alpha-linoleic) gm 2000, long chain N3 fatty acid, omega-6 (c182s, Arachadonic fatty 
acid gm, no gamma-linolenic acid) gm, omega-6 w/o supplements, long chain N3 fatty acid w/o 
supplements, omega-6 w/o supplements], fatty acids (oleic acid gm, butyric fatty acid gm, 
caproic fatty acid gm, caprylic fatty acid gm, capric fatty acid gm, lauric fatty acid gm, myristic 
fatty acid gm, palmitic fatty acid gm, stearic fatty acid gm, palmitoleic fatty acid gm, eicosenoic 
fatty acid gm, arachadonic fatty acid gm), carbohydrates (carbohydrates gm, lactose gm, 
fructose gm), amino acid (protein gm, methionine gm, animal protein gm, tryptophan gm, 
glutamate gm, aspartate gm), A vitamins (retinol IU, carotene IU, vitamin A IU , retinol w/o 
supplement, vitamin A w/o supplements, alpha carotene mcg, beta carotene mcg, beta 
cryptoxanthin mcg, lycopene mcg, lutein and zeaxanthin mcg, retinol equivalents of vitamin A 
mcg, retinol activity equivalents mcg, retinol equivalents of vitamin A without supplements, retinol 
activity equivalents without supplements, carotene without supplements, beta carotene without 
supplements), B vitamins (vitamin B-1 mg, vitamin B-2 mg, niacin mg, vitamin B-6 mg, 
pantothenic acid mg, vitamin B-1 without supplements, vitamin B-2 without supplements, vitamin 
B-6 without supplements, niacin without supplements, pantothenic acid without supplements), B-
12 vitamins (total folate post 1998 mcg includes supplements and fortified foods, vitamin b12 
mcg, total folate without supplements, vitamin B-12 without supplements, natural food folate 
2001 mcg , folic acid from supplements and fortified foods 2001 mcg, folate equivalents mcg 
includes supplements and fortified foods), C vitamins (vitamin C mg, vitamin C without vitamin 
pills), D and E vitamins (vitamin D IU, vitamin D without vitamin pills, total vitamin E mg atoco 
includes supplements and fortified foods, vitamin E mg atoco  from food fortification only 
synthetic, vitamin E mg atoco w/out vitamin supplementation mcg includes fortified foods), 
minerals (calcium mg, iron mg, magnesium mg, phosphorous mg, potassium mg, zinc mg, 
sodium mg, manganese mg, calcium without vitamin pills, iron without vitamin pills, zinc without 
vitamin pills , phosphorous without vitamin pills, potassium without vitamin pills, magnesium 
without vitamin pills, manganese without vitamin pills), and trace elements (iodine mcg, 
selenium mcg, copper mg, copper without supplements).   Unrotated PCA (Stata 9, College 
Station, TX; SPSS 14, Chicago, IL) was performed on the set of variables in each of the 12 food 
groups described above.  PC extraction was based on components for which eigenvalues 
exceeded a value of 2, which mostly resulted in only one PC.   However, on occasion, there were 
2 PCs for which the eigenvalues exceeded a value of 2.  
 
Statistical analysis: group differences. Although the recruitment process was designed to 
match proportions of subjects in each study group within age decade brackets, there remain 
many potential cataract-causative differences between individuals that might not have been 
balanced in the realized study design. Further, during the cross-sectional analysis, it was 
imperative to identify confounding variables which were both significantly different across the 
three groups and potentially explanatory for the prevalence of cataract.  Hypothesis testing was 
performed using chi-square contingency analysis for nominally-scaled variables (Table 4) and 
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Kruskal-Wallis non-parametric ANOVA for continuously-scaled variables (Table 5). The 
groupwise difference in continuously-scaled PCs for nutritional data was evaluated by performing 
Kruskal-Wallis non-parametric ANOVA on PC scores for only the first extracted PC for each of 
the 12 food groups (Stata 9, College Station, TX; SPSS 14, Chicago, IL). Measurements made 
on eye pairs were combined using the maximum value or measurement obtained from the 
"worst" eye as the dependent variable. Variables showing significant differences were flagged if 
p-values, adjusted for correlated multiple testing were less than 0.05 (6). It is intended that 
adjustment for differences in the significant variables would be made via regression models in 
the next analytical phase of the study.  All statistical analysis involving chi-square tables, Kruskal-
Wallis ANOVA, and Westfall-Young FWER were performed independently by both AF and LP 
and yielded identical results.    
 
Statistical analysis: Propensity scores.   An ideal goal for observational etiological studies is 
to randomly allocate subjects into different treatment groups in order to guarantee on average 
that there are no systematic differences in covariates between groups(18,19).  NASCA, however, 
is a non-randomized study in which there is no control over group (treatment) assignment of 
subjects into the astronaut and control categories. Therefore, large differences could occur in 
observed covariates which may lead to bias in the effect of space radiation on cataract.  The 
propensity score provides a scalar summary of covariate information and is defined as the 
propensity (probability) that a subject’s covariate profile represents subjects truly assigned to a 
given treatment group.  Propensity scores based on significantly different confounder variables 
can be used to create a quasi-randomized experiment with adjustment to the treatment effect. 
The BioMedStat program (http://www.chipst2c.org/BioMedStat.html) was used to perform 
polytomous logistic regression in which class membership was regressed on categorical and 
continuous confounder variables identified to be significantly different between the 3 groups.  P-
values for significant categorical confounder variables were determined using log-linear 
regression (SPSS Version 14, Chicago(IL)) with the vector of propensity scores used as a 
covariate.  P-values for significant continuously-scaled confounder variables were assessed 
using univariate GLM (SPSS Version 14, Chicago, IL) with propensity scores serving as a 
covariate. In addition, for continuously-scaled confounder variables, log-normal transformations 
were performed in order to assure normality.         
 
 
RESULTS 
 
Enrollment.  A major goal of NASA in funding the NASCA study was to gain additional 
perspective on the issues and findings of the first study of cataract in astronauts(1). The lens 
opacity classification method used in (1) was not standardized or validated, and the terms used 
to describe the type and severities of various opacities (See Column 1 of Table 3) were not the 
same as will be used in NASCA. There are additional differences between the original and the 
NASCA study populations of astronauts. These are evident in the lower half of Table 3. It is clear 
that in NASCA we have only 14/25 of the astronauts with non-trace cataract and only 26/48 of 
those with all grades of cataract. In the interim between the two studies five astronauts died, 6 
had cataract surgery with IOL implantation, and 13 elected not to participate. These several 
differences suggest that a strict comparison of the results of the original and NASCA studies is 
not warranted.  
 
Table 1, columns 2 and 3, compares the number of astronauts participating in the various NASA 
manned space programs who were subjects in the Cucinotta et al study(1), to the number of 
astronauts (and lenses) available for the NASCA study. Fifty-nine percent (59%) of those 
participating in the Cucinotta study (1) are participating in NASCA.  Recruitment in NASCA 
started on May 5, 2004 and ended on May 16, 2006.  Our goal was to enroll and match the 285 
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US astronauts living when NASCA started by gender and age group to 100 aircrew exposure 
controls and 100 ground-based exposure controls.  This resulted in a nominal 1.4:1 matching 
ratio.  Table 2 lists the recruitment data presented by decade for the first year of the NASCA 
project. The ground-based exposure control group had more young (<30y) individuals than the 
astronauts and aircrew exposure controls, and the aircrew exposure controls had more 
individuals in the 40-50y age group. Otherwise, the groups were well balanced in terms of the 
distribution of subjects by age decade.  At this time, 230 astronauts have elected to join the 
NASCA study, which is lower than our original expectation. 
 
Groupwise differences.   Table 4 lists the group-specific frequencies (counts) and percentage 
of responses within categorical variable measured in the NASCA study.   Chi-square P-values for 
tests of independence of categorical variables in Table 4 are listed.   In order to incorporate 
correlation into significance tests, we ran Westfall-Young family wise error rates (FWER) for all 
variables.  After adjusting for correlation, only 4 variables were significant:  history of asthma 
(p=0.0041), history of hypertension (p=0.0004), history of obesity (p=0.0354), and number of 
medications reported taking (p=0.0017).  Tests for ethnicity, racial category, tobacco usage, and 
all other histories of disease were not significantly different.  Table 5 lists the group-specific 
average and standard deviation (s.d.) for each continuously scaled variable.   FWER p-values for 
continuous variables were only significant for high contrast logMAR (p=0.0186).   Solar ocular 
exposure was quite skewed having quartile values of 8.4, 18.1, 41.1 for astronauts of, 10.2, 22.1, 
and 58.3 for aircrew controls, and 9.9, 25.6, 48.6 for ground controls.   Figure 2 shows the 
significant correlation between age at baseline and the natural logarithm of effective ocular 
exposure (Pearson r=0.476, P<0.0005; Spearman rank r=0.454, P<0.0005).   
 
Propensity scores.  Propensity scores for each subject were generated by using polytomous 
logistic regression in which the 3 binarized (1-yes,0-no) group membership variables were 
regressed on the significant categorical confounder variables (history of asthma, history of 
hypertension, history of obesity, number of medications reported taking, and the single 
continuously-scaled confounder (high contrast logMAR).  Propensity scores for subjects in each 
of the 3 groups are shown in Figure 3.   In Figure 3A, one can notice that there is overlap of 
scores and astronauts have a greater propensity for having confounder profiles similar to military 
aviators rather than ground controls.  There were also 16 astronauts with greater propensity 
scores for the ground control group compared with their own group, but this rapidly degenerates 
since most astronauts took on propensity scores that are representative of their own group.  
Interestingly, almost all of the astronauts have a 0.2 propensity for having confounder profiles of 
military aviators.  This is in agreement with the large proportion of military aviators (Figure 3B) 
with propensity scores greater than 0.5 for which confounder profiles represent those of the 
astronauts.   Thus, the military aviator control group has a greater propensity for having 
confounder profiles similar to astronauts when compared with controls.   For ground controls 
(Figure 3C), the majority of subjects had confounder profiles similar to astronauts and military 
aviators, with the remaining scores reflecting confounder profiles unique to ground controls.   
Lastly, Figure 3D shows the quantiles for P(astronaut) for the 3 groups, which suggests that for 
confounder profiles, the entire military aviator control group is more similar to the astronauts 
when compared with the ground controls.     
 
The ability of propensity scores to balance differences between confounder variables across 
groups was evaluated using the propensity score for astronauts [i.e., P(astronaut)] for all subjects 
as a model covariate in log-linear regression (for categorical confounders) and GLM (for 
continuous confounders).  Results indicate that the original chi-square p-value for history of 
asthma changed from <0.0005 to 0.127, for history of hypertension from <0.0005 to 0.801, for 
history of obesity from 0.005 to 0.080, and for number of mediciation reported talking from 
<0.0005 to 0.005.  The Kruskal-Wallis p-value of 0.001 for the continuous confounder high 
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contrast logMAR changed to 0.894 after a loge transformation (0.31+high contrast logMAR) and 
adjustment for propensity scores using GLM.    
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
Radiation protection during prolonged manned flight to the moon and Mars is a major challenge 
that warrants continual research on bioeffects in order to minimize crew health risks.  NASA 
places a high priority on crew radiation protection, and therefore supports the NASCA project.   
The primary reason for undertaking the NASCA study is to develop a more complete picture 
surrounding the new insights on cataract and space radiation exposure reported in Cucinotta et 
al.’s original paper (1). Different methods were used in NASCA, so we cannot precisely compare 
NASCA results to those of (1).   
 
Efforts to recruit subjects in the NASCA study have been non-problematic and relatively 
straightforward.  Varying levels of selection bias do exist depending on the group being 
considered.   While many of the retired US astronauts have enrolled in NASCA, we have not 
been able to enroll the entire corp of retired US astronauts due to the impracticality of long-
distance travel by those who have moved out of the study area.   (this statement needs to be 
supported by comparing the distribution of dose for all astronauts vs. the distribution of NASCA 
astronauts -  I have asked for these data from Frank during 11/15 conf call, and I will do the 
analysis).  The majority of retired astronauts participate annually in the LSAH, returning each 
year via NASA-supported travel to the Lyndon B. Johnson Space Center for their annual follow-
up physical -- and the majority of these are enrolled in NASCA.   Several retired astronauts with 
previous space flight experience (i.e. space radiation exposure) were excluded from enrollment 
as a result of previous ophthalmological procedures.    
 
We want to describe the success of the recruitment effort and the causes for non-participation of 
dropouts.  [Dale and Lisa, we need a summary of disqualification reasons and dropouts 
assuming we know why they dropped out – include quantity of dropouts and a breakdown for 
astronauts and control types.  Also, send their ID number so I can look at their baseline data.] 
 
We also want to emphasize that we have gathered nutritional data with a validated instrument 
and describe the rationale for and the approach used in analyzing the nutritional data (principal 
components).   
 
(Nutritional data were collected due to published reports on known cataractogenic risks and 
protective effects of certain nutrients. Need citations. Leo, based on your previous published 
epidemiologic studies, can you send relevant descriptions and citations for collecting the 
nutritional data.)   
 
We want to comment on the solar UV and space-radiation exposure data. Leif and Frank, what 
are the key points to be discussed here?  (I need to run correlations between age and solar to 
show how correlated they are).  
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We want to describe our goals for the short-term (cross-sectional) and the long-term phases of 
the NASCA program and the feasibility of reaching these goals. 
 
(Cross-sectional) - To accurately assess the relationship of doses of space radiation, age, 
gender, solar UV exposure, and nutrition to the risk of lens opacification (cortical, nuclear, and 
posterior subcapsular) and nuclear color. 
(Longitudinal) - To accurately assess the relationship of doses of space radiation, age, gender, 
solar UV exposure, and nutrition to the risk of progression of lens opacification (cortical, nuclear, 
and posterior subcapsular) and nuclear color. 
(Longitudinal) -To identify nutrients or nutritional patterns that are associated with reduced risk of 
having lens opacification or progression of lens opacification. 
To identify nutrients that may be associated with cataract and their interactions with other factors 
(e.g. space radiation). 
 
The significant confounder variables used to develop propensity scores meet requirements for 
being pretreatment covariates related to group membership.   A positive history of asthma, 
positive history of obesity, positive history of hypertension, number of medications reported 
taking, and high contrast logMAR are clinical selection criteria used during new astronaut 
screening.    
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TABLE CAPTIONS: 
 
Legend Table 1: Characteristics of participants in NASA missions 
 
Legend Table 2: Recruitment for NASCA Study by Decade 
 
Legend Table 3: (new wording): The upper half of this table compares by cataract class (as 
defined in the original study) the number of astronauts from the original study that are 
participating in the NASCA study. The lower half of the able enumerates the reasons astronauts 
who participated in the original study elected not to participate in NASCA.  
 
Legend Table 4: We can provide the definitions of the various abbreviations, but we should wait 
until we know the results of the Kruskal-Wallis analyses since many of the comparisons may 
show now statistically significant differences. We would then omit the variables for which there 
are non-significant differences from this table. 
 
Legend Table 5: Basic baseline data on visual function and other ocular measures. 
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Table 1. Characteristics of participants in NASA missions. 
 
Mission (time periods) Number of 
Astronauts
NASCA Participants (# 
of lenses at risk) 
Average Mission 
Lens Dose, mSv 
Apollo  (1968  - 1972) 24 8   (16)   15.1 
Skylab (1973  - 1974)   9 4   (7) 129.3 
Mir       (1995  - 1998)   7 6   (12) 114.3 
ISS 13 10 (20)   73.5 
Hubble Repair (1989 – 2003) 42 28 (56)   31.2 
Total 90 53 (59% overall 
participation) 
 
 
[why is Shuttle ignored? If the radiation exposure is negligible, we need to state that in the text 
and perhaps also as a footnote to this table. Same for Mercury, Gemini and Apollo-Soyuz Test 
Project missions.] 
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Table 2:   Recruitment for NASCA study by age and subject group. 
 
Subject Group, N(%)     
Age Group Astronauts Aircrew Ground-
controls 
Total 
     <30       0(0.0)   0(0.0)     2(2.0)     2 (10.7)
   30-39     20(8.7) 10(10.4)   14(14.0)   44 (37.2)
   40-49   100(43.5) 24(25.0)   36(36.0) 160 (31.2)
   50-59     66(28.7) 40(41.7)   28(28.0) 134 (0.9)
   60-69     27(11.7) 13(13.5)   14(14.0)   54 (12.6)
     70+     17(7.4)   9(9.4)     6(6.0)   32 (7.4)
   Total  230(100.0) 96(100.0) 100(100.0) 426(100.0)
 
[I think it would be helpful to the readers to present the age distribution of the original 285 US 
astronauts. This would assist in comparing all three study groups to the population standard.  It 
would also clarify why our subject distribution has this shape and why few subjects <30 were 
recruited. MW] 
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Table 3. Comparison of astronaut participation in NASCA and in study by Cucinotta et al. 
(1). 
 
Non-Trace All Cataracts  
 
Cataract Type 
Cucinotta et al., 
2001 
NASCA Cucinotta et al., 
2001 
NASCA 
PSC 3 2 5 3 
ASC/Congenital 1 0 1 0 
Cortical 9 7 20 14 
Nuclear 6 1 8 2 
PSC & CS 3 1 3 1 
ASC& CS 1 0 1 0 
CS & Nuclear 0 1 6 3 
Dot Opacities 2 2 4 3 
Total 25 14 48 26 
 Reason for Non-Participation in NASCA 
 Non-Trace All cataracts 
Deceased - 2 - 3 
Lens Implant 
Surgery 
- 6 - 6 
Other - 1 - 3 
Lack of consent 
or unknown 
- 3 - 10 
Total Non-
participants 
- 12 - 22 
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Table 4.  Nominally-scaled demographic and general health variables [count(%)] 
assessed for confounding by using chi-square contingency table analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aWestfall-Young FWER p-values for history of hypertension (0.0004), #medications reported (0.0017), 
history of asthma (0.0041), and history of obesity (0.0354).    
bP-value for groupwise difference using log-linear model with propensity score as a covariate.    
 
Subject Group  
 
 
Variable Astronauts Aircrew
Ground-
based 
controls
 
 
Chi-square 
P-value 
Male/Female 172/34 79/5 77/19 0.024
Ethnicity                     Not Hispanic 176(95.1) 78(97.5) 68(93.2)
     Hispanic or Latino 9(4.9) 2(2.5) 4(5.5)
     Other - - 1(1.4)
0.326
Race                                      White 171(92.4) 73(93.1) 66(90.4)
Black or African-American 6(3.2) 2(2.5) 2(2.7)
Asian 5(2.7) 2(2.5) 3(4.1)
American Indian/Alaskan Native 3(1.6) 2(2.5) 1(1.4)
Native Hawaiian or other Pacific 
Islander  - - -
Other - 1(1.3) 1(1.4)
0.912
History of asthma 2(0.1) 1(0.9) 10(10) <0.0005a
History of diabetes 1(0.5) - 1(1) 0.602
History of eye surgery 9(4.1) 6(6.3) 5(5) 0.707
History of gout 1(0.5) 3(3.2) - 0.043
History of hypertension 13(6) 15(15.8) 24(24) <0.0005a
History of macular degeneration 2(0.9) 1(1.1) 2(2) 0.706
History of obesity - 5(5.3) 3(3) 0.005a
Prev. tobacco use(cigarette) 27(15) 21(26.9) 14(19.7) 0.078
Prev. tobacco use(cigar) 19(11.7) 19(27.5) 13(19.4) 0.012
#Medications reported taking         0 129(59.2) 44(46.3) 33(33)
1 46(21.1) 20(21.1) 24(24)
2 23(10.6) 12(12.6) 14(14)
3 7(3.2) 11(11.6) 14(14)
4 11(5) 6(6.3) 6(6)
5 2(0.9) 2(2.1) 4(4)
6 - - 3(3)
7 - - 1(1)
8 - - 1(1)
<0.0005a
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Table 5. Continuously-scaled demographic, ocular, space radiation, and nutritional 
variables [average (s.d.)] assessed for confounding by using non-parametric Kruskal-
Wallis tests.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aMean (s.d.) of max{od,os}.  
bOutcome variable, not used in Westfall-Young FWER analysis  
cMean (s.d.) of principal component scores based on first principal component extracted without rotation.  
dWestfall-Young FWER p-value for high contrast logMAR (0.0186).    
eP-value for groupwise differrence of loge(0.31+high contrast logMAR) adjusted for propensity scores using 
GLM was was 0.894.  
 
Subject Group  
 
Variable Astronauts Aircrew
 
Ground-based 
controls 
Kruskal-
Wallis 
P-value 
Age (years) 51.24(9.9) 53.84(10.04) 50.57(10.78) 0.02
High contrast logMARa -0.13(0.09) -0.11(0.09) -0.08(0.13) 0.001d,e
Low contrast logMARa 0.22(0.12) 0.24(0.12) 0.28(0.18) 0.015
Color vision test #1 scorea 13.94(1.24) 13.93(0.59) 13.69(1.19) 0.008
LOCS III nuclear colora 1.35(0.5) 1.52(0.7) 1.53(0.85) 0.241
Intraocular pressurea 16.3(3.4) 16.5(3.02) 15.7(2.5) 0.199
nuc1a,b 52.09(18.71) 60.9(25.92) 56.35(26.31) 0.007
nuc2a,b 63.24(22.34) 72.63(27.47) 68.1(28.49) 0.002
nuc3a,b 77.16(21.45) 85.52(23.5) 79.98(24.98) 0.005
corta,b 1.65(5.58) 1.33(2.64) 2.43(6.56) 0.059
PSCa,b 0.18(0.99) 0.28(1.08) 0.9(6.47) 0.371
Solar (OEeff, sun-years) 35.28(52.47) 42.05(60.42) 40.5(52.07) 0.188
Space radiation dose 
(mSv) 
0,8.47,19.77 - - -
Space radiation dose x 
latency (mSv-y) 
0,86.92,186.02 - - -
Fatsc -0.2(2.29) 0.06(2.22) 0.4(2.54) 0.107
Omega fatty acidsc -0.12(2.11) 0.55(3.3) -0.24(2.7) 0.095
Fatty acidsc -0.04(2.88) -0.19(2.37) 0.28(2.97) 0.600
Carbohydratesc 0.03(1.57) -0.14(1.69) 0.09(1.91) 0.538
B Vitaminsc -0.15(2.08) -0.05(2.11) 0.36(2.22) 0.243
Folic Acid, Vitamin B12c 0.01(1.8) -0.23(1.72) 0.18(2.19) 0.497
A Vitaminsc 0.02(2.65) -0.06(3.31) -0.01(3.11) 0.595
Amino acidsc -0.13(2.22) 0.03(2.78) 0.28(2.51) 0.422
Mineralsc 0.08(2.17) -0.16(2.71) -0.01(2.43) 0.48
Trace elementsc 0.04(1.42) -0.08(1.43) -0.0042(1.5259) 0.805
D and E Vitaminsc -0.02(1.23) 0.16(1.52) -0.09(1.51) 0.615
C Vitaminsc 0.11(1.09) -0.13(1.01) -0.11(1.17) 0.04
Alcohol (gm-d-1) 20.74(8.73) 20.39(10.72) 20.62(8.69) 0.75
Fiber (gm-d-1) 10.31(9.74) 9.59(11.13) 10.3(13.79) 0.15
Caffeine (mg-d-1) 204.08(183.65) 217.43(191.05) 202.41(190.41) 0.779
Calories (-d-1) 1964.06(659.29) 1937.07(648) 2061.13(746.46) 0.566
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FIGURE CAPTIONS: 
 
Figure 1.   Distribution and enrollment of all subjects expressing an interest in participating in the 
NASCA project.   
 
Figure 2.  Natural logarithm of effective ocular exposure (sun-years) as a function of age at 
baseline. 
 
Figure 3.   Propensity scores for astronauts and the two control groups (military aviators and 
ground controls).   The propensity score is equal to the probability of group membership [i.e., 
P(Astronaut), P(Military aviator), and P(Ground control)] from polytomous logistic regression, 
given the covariate profile.  Covariates used in polytomous logistic regression were confounder 
variables found to be significantly different between the 3 groups (history of asthma, history of 
hypertension, history of obesity, number of medications reported taking, and high contrast 
logMAR).  3A: Propensity scores predicted for with confounder values for astronauts.  Several 
astronauts reflect confounder profiles more similar to military aviators or ground controls and 
interestingly have an invariant score of 0.2 for military aviators.   3B: scores predicted with 
confounder values for military aviators, showing that the majority have confounder profiles similar 
to astronauts, whereas (3C) ground controls have more confounder profiles unlike astronauts.  
3D:  Quantiles of P(Astronaut) for the 3 groups.   Military aviator controls have confounder 
profiles more similar to astronauts when compared with ground controls.   
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Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consenting Subjects Participating 
in NASCA  
(N = 490)
Met all inclusion/exclusion criteria 
(eligibles) and were consented and 
designated active subjects 
(N = 425) 
Did not meet all inclusion/exclusion criteria and 
were excluded. 
(N = 55) 
Given baseline examination 
(N = 425) 
No findings on exam justifying exclusion 
(N = 419) 
Excluded on the basis of findings of baseline exam 
(N = 6) 
Completed full NASCA Protocol 
(N = 419) 
Dropouts 
(N = 6) 
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